AAAAAA

   
Results: 1-10 |
Results: 10
NONCLINICAL TOXICOLOGY STUDIES WITH ZIDOVUDINE - ACUTE, SUBACUTE, ANDCHRONIC TOXICITY IN RODENTS, DOGS, AND MONKEYS
Authors: AYERS KM TUCKER WE HAJIAN G DEMIRANDA P
Citation: Km. Ayers et al., NONCLINICAL TOXICOLOGY STUDIES WITH ZIDOVUDINE - ACUTE, SUBACUTE, ANDCHRONIC TOXICITY IN RODENTS, DOGS, AND MONKEYS, Fundamental and applied toxicology, 32(2), 1996, pp. 129-139
NONCLINICAL TOXICOLOGY STUDIES WITH ZIDOVUDINE - REPRODUCTIVE TOXICITY STUDIES IN RATS AND RABBITS
Authors: GREENE JA AYERS KM TUCKER WE DEMIRANDA P
Citation: Ja. Greene et al., NONCLINICAL TOXICOLOGY STUDIES WITH ZIDOVUDINE - REPRODUCTIVE TOXICITY STUDIES IN RATS AND RABBITS, Fundamental and applied toxicology, 32(2), 1996, pp. 140-147
NONCLINICAL TOXICOLOGY STUDIES WITH ZIDOVUDINE - GENETIC TOXICITY TESTS AND CARCINOGENICITY BIOASSAYS IN MICE AND RATS
Authors: AYERS KM CLIVE D TUCKER WE HAJIAN G DEMIRANDA P
Citation: Km. Ayers et al., NONCLINICAL TOXICOLOGY STUDIES WITH ZIDOVUDINE - GENETIC TOXICITY TESTS AND CARCINOGENICITY BIOASSAYS IN MICE AND RATS, Fundamental and applied toxicology, 32(2), 1996, pp. 148-158
METABOLISM AND PHARMACOKINETICS OF A DOUBLE PRODRUG OF GANCICLOVIR INTHE RAT AND MONKEY
Authors: KRASNY HC BEAUCHAMP L KRENITSKY TA DEMIRANDA P
Citation: Hc. Krasny et al., METABOLISM AND PHARMACOKINETICS OF A DOUBLE PRODRUG OF GANCICLOVIR INTHE RAT AND MONKEY, Drug metabolism and disposition, 23(11), 1995, pp. 1242-1247
PURIFICATION AND CHARACTERIZATION OF A RAT-LIVER ENZYME THAT HYDROLYZES VALACICLOVIR, THE L-VALYL ESTER PRODRUG OF ACYCLOVIR
Authors: BURNETTE TC HARRINGTON JA REARDON JE MERRILL BM DEMIRANDA P
Citation: Tc. Burnette et al., PURIFICATION AND CHARACTERIZATION OF A RAT-LIVER ENZYME THAT HYDROLYZES VALACICLOVIR, THE L-VALYL ESTER PRODRUG OF ACYCLOVIR, The Journal of biological chemistry, 270(26), 1995, pp. 15827-15831
NOVEL CARBOHYDRATE CONJUGATES AS POTENTIAL PRODRUGS OF ACYCLOVIR
Authors: CHAMBERLAIN SD MOORMAN AR BURNETTE TC DEMIRANDA P KRENITSKY TA
Citation: Sd. Chamberlain et al., NOVEL CARBOHYDRATE CONJUGATES AS POTENTIAL PRODRUGS OF ACYCLOVIR, Antiviral chemistry & chemotherapy, 5(2), 1994, pp. 64-73
METABOLIC-FATE AND PHARMACOKINETICS OF THE ACYCLOVIR PRODRUG VALACICLOVIR IN CYNOMOLGUS MONKEYS
Authors: DEMIRANDA P BURNETTE TC
Citation: P. Demiranda et Tc. Burnette, METABOLIC-FATE AND PHARMACOKINETICS OF THE ACYCLOVIR PRODRUG VALACICLOVIR IN CYNOMOLGUS MONKEYS, Drug metabolism and disposition, 22(1), 1994, pp. 55-59
METABOLIC DISPOSITION OF THE ACYCLOVIR PRODRUG VALACICLOVIR IN THE RAT
Authors: BURNETTE TC DEMIRANDA P
Citation: Tc. Burnette et P. Demiranda, METABOLIC DISPOSITION OF THE ACYCLOVIR PRODRUG VALACICLOVIR IN THE RAT, Drug metabolism and disposition, 22(1), 1994, pp. 60-64
REVIEW OF RESEARCH LEADING TO NEW ANTI-HERPESVIRUS AGENTS IN CLINICALDEVELOPMENT - VALACICLOVIR HYDROCHLORIDE (256U, THE L-VALYL ESTER OF ACYCLOVIR) AND 882C, A SPECIFIC AGENT FOR VARICELLA-ZOSTER VIRUS
Authors: PURIFOY DJM BEAUCHAMP LM DEMIRANDA P ERTL P LACEY S ROBERTS G RAHIM SG DARBY G KRENITSKY TA POWELL KL
Citation: Djm. Purifoy et al., REVIEW OF RESEARCH LEADING TO NEW ANTI-HERPESVIRUS AGENTS IN CLINICALDEVELOPMENT - VALACICLOVIR HYDROCHLORIDE (256U, THE L-VALYL ESTER OF ACYCLOVIR) AND 882C, A SPECIFIC AGENT FOR VARICELLA-ZOSTER VIRUS, Journal of medical virology, 1993, pp. 139-145
PHARMACOKINETICS OF THE ACYCLOVIR PRO-DRUG VALACICLOVIR AFTER ESCALATING SINGLE-DOSE AND MULTIPLE-DOSE ADMINISTRATION TO NORMAL VOLUNTEERS
Authors: WELLER S BLUM MR DOUCETTE M BURNETTE T CEDERBERG DM DEMIRANDA P SMILEY ML
Citation: S. Weller et al., PHARMACOKINETICS OF THE ACYCLOVIR PRO-DRUG VALACICLOVIR AFTER ESCALATING SINGLE-DOSE AND MULTIPLE-DOSE ADMINISTRATION TO NORMAL VOLUNTEERS, Clinical pharmacology and therapeutics, 54(6), 1993, pp. 595-605
Risultati: 1-10 |